145 related articles for article (PubMed ID: 33468393)
1. Decreased Overall Survival in HIV-associated Non-small-cell Lung Cancer.
Hysell K; Yusuf R; Barakat L; Virata M; Gan G; Deng Y; Perez-Irizarry J; Vega T; Goldberg SB; Emu B
Clin Lung Cancer; 2021 Jul; 22(4):e498-e505. PubMed ID: 33468393
[TBL] [Abstract][Full Text] [Related]
2. Effect of HIV on survival in patients with non-small-cell lung cancer in the era of highly active antiretroviral therapy: a population-based study.
Rengan R; Mitra N; Liao K; Armstrong K; Vachani A
Lancet Oncol; 2012 Dec; 13(12):1203-9. PubMed ID: 23164952
[TBL] [Abstract][Full Text] [Related]
3. Human immunodeficiency virus infection as a prognostic factor in surgical patients with non-small cell lung cancer.
Hooker CM; Meguid RA; Hulbert A; Taylor JT; Shin J; Wrangle J; Rodgers K; Lee B; Laskshmanan S; Brown T; Meneshian A; Sussman M; Keruly J; Moore RD; Yang SC; Brock MV
Ann Thorac Surg; 2012 Feb; 93(2):405-12. PubMed ID: 22269705
[TBL] [Abstract][Full Text] [Related]
4. Disparities in the treatment and outcomes of lung cancer among HIV-infected individuals.
Suneja G; Shiels MS; Melville SK; Williams MA; Rengan R; Engels EA
AIDS; 2013 Jan; 27(3):459-68. PubMed ID: 23079809
[TBL] [Abstract][Full Text] [Related]
5. Development and Validation of a Deep Learning Model for Non-Small Cell Lung Cancer Survival.
She Y; Jin Z; Wu J; Deng J; Zhang L; Su H; Jiang G; Liu H; Xie D; Cao N; Ren Y; Chen C
JAMA Netw Open; 2020 Jun; 3(6):e205842. PubMed ID: 32492161
[TBL] [Abstract][Full Text] [Related]
6. The impact of histology in the outcomes of patients with early-stage non-small cell lung cancer (NSCLC) treated with stereotactic body radiation therapy (SBRT) and adjuvant chemotherapy.
Ernani V; Appiah AK; Baine MJ; Smith LM; Ganti AK
Cancer Treat Res Commun; 2020; 24():100197. PubMed ID: 32777751
[TBL] [Abstract][Full Text] [Related]
7. Socioeconomic disparities in lung cancer treatment and outcomes persist within a single academic medical center.
Yorio JT; Yan J; Xie Y; Gerber DE
Clin Lung Cancer; 2012 Nov; 13(6):448-57. PubMed ID: 22512997
[TBL] [Abstract][Full Text] [Related]
8. Pulmonologist involvement, stage-specific treatment, and survival in adults with non-small cell lung cancer and chronic obstructive pulmonary disease.
Deepak JA; Ng X; Feliciano J; Mao L; Davidoff AJ
Ann Am Thorac Soc; 2015 May; 12(5):742-51. PubMed ID: 25760983
[TBL] [Abstract][Full Text] [Related]
9. The effect of tumor laterality on survival for non-small cell lung cancer patients treated with radiotherapy.
Jørgensen N; Meline EL; Jeppesen SS; Hansen O; Nielsen M; Schytte T
Acta Oncol; 2019 Oct; 58(10):1393-1398. PubMed ID: 31271075
[No Abstract] [Full Text] [Related]
10. Treatment Patterns and Differences in Survival of Non-Small Cell Lung Cancer Patients Between Academic and Non-Academic Hospitals in the Netherlands.
van der Linden N; Bongers ML; Coupé VMH; Smit EF; Groen HJM; Welling A; Schramel FMNH; Uyl-de Groot CA
Clin Lung Cancer; 2017 Sep; 18(5):e341-e347. PubMed ID: 28347579
[TBL] [Abstract][Full Text] [Related]
11. Mortality among people living with HIV/AIDS with non-small-cell lung cancer in the modern HAART Era.
Smith DM; Salters KA; Eyawo O; Franco-Villalobos C; Jabbari S; Wiseman SM; Press N; Montaner JSG; Man SFP; Hull M; Hogg RS
AIDS Care; 2018 Jul; 30(7):936-942. PubMed ID: 29411625
[TBL] [Abstract][Full Text] [Related]
12. Comparison of survival and hospitalization rates between Medicare patients with advanced NSCLC treated with bevacizumab-carboplatin-paclitaxel and carboplatin-paclitaxel: a retrospective cohort study.
Langer C; Ravelo A; Hazard SJ; Guerin A; Ionescu-Ittu R; Latremouille-Viau D; Wu EQ; Ramalingam S
Lung Cancer; 2014 Dec; 86(3):350-7. PubMed ID: 25439437
[TBL] [Abstract][Full Text] [Related]
13. Human immunodeficiency virus infection and non-small cell lung cancer: survival and toxicity of antineoplastic chemotherapy in a cohort study.
Makinson A; Tenon JC; Eymard-Duvernay S; Pujol JL; Allavena C; Cuzin L; Poizot-Martin I; de la Tribonnière X; Cabié A; Pugliese P; Reynes J; Le Moing V
J Thorac Oncol; 2011 Jun; 6(6):1022-9. PubMed ID: 21512403
[TBL] [Abstract][Full Text] [Related]
14. Treatment and survival of patients with EGFR-mutated non-small cell lung cancer and leptomeningeal metastasis: A retrospective cohort analysis.
Kuiper JL; Hendriks LE; van der Wekken AJ; de Langen AJ; Bahce I; Thunnissen E; Heideman DA; Berk Y; Buijs EJ; Speel EJ; Krouwels FH; Smit HJ; Groen HJ; Dingemans AM; Smit EF
Lung Cancer; 2015 Sep; 89(3):255-61. PubMed ID: 26117231
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Survival Rates After a Combination of Local Treatment and Systemic Therapy vs Systemic Therapy Alone for Treatment of Stage IV Non-Small Cell Lung Cancer.
Uhlig J; Case MD; Blasberg JD; Boffa DJ; Chiang A; Gettinger SN; Kim HS
JAMA Netw Open; 2019 Aug; 2(8):e199702. PubMed ID: 31433481
[TBL] [Abstract][Full Text] [Related]
16. Timeliness of Treatment Initiation and Associated Survival Following Diagnosis of Non-Small-Cell Lung Cancer in South Carolina.
Bullard JT; Eberth JM; Arrington AK; Adams SA; Cheng X; Salloum RG
South Med J; 2017 Feb; 110(2):107-113. PubMed ID: 28158880
[TBL] [Abstract][Full Text] [Related]
17. Comparative survival in patients with postresection recurrent versus newly diagnosed non-small-cell lung cancer treated with radiotherapy.
Cai XW; Xu LY; Wang L; Hayman JA; Chang AC; Pickens A; Cease KB; Orringer MB; Kong FM
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1100-5. PubMed ID: 19540063
[TBL] [Abstract][Full Text] [Related]
18. Real-world treatment patterns and survival outcomes for advanced non-small cell lung cancer in the pre-immunotherapy era in Portugal: a retrospective analysis from the I-O Optimise initiative.
Soares M; Antunes L; Redondo P; Borges M; Hermans R; Patel D; Grimson F; Munro R; Chaib C; Lacoin L; Daumont M; Penrod JR; O'Donnell JC; Bento MJ; Rocha Gonçalves F
BMC Pulm Med; 2020 Sep; 20(1):240. PubMed ID: 32912174
[TBL] [Abstract][Full Text] [Related]
19. Comparison of stereotactic body radiation therapy for biopsy-proven versus radiographically diagnosed early-stage non-small lung cancer: a single-institution experience.
Fischer-Valuck BW; Boggs H; Katz S; Durci M; Acharya S; Rosen LR
Tumori; 2015; 101(3):287-93. PubMed ID: 25908031
[TBL] [Abstract][Full Text] [Related]
20. Local tumor response and survival outcomes after combined stereotactic radiosurgery and immunotherapy in non-small cell lung cancer with brain metastases.
Singh C; Qian JM; Yu JB; Chiang VL
J Neurosurg; 2019 Feb; 132(2):512-517. PubMed ID: 30771783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
